Opioid Market Size Anticipated to Climb to USD 26.41 Billion with 1.5% Annual Growth by 2032 | Key Players- Cadila Healthcare Limited, Fresenius Kabi, Mallinckrodt Pharmaceuticals

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

• The opioid market size was valued at USD 23.10 billion in 2023
• The market is expected to expand at a CAGR of 1.5% from 2024 to 2032
• The market is expected to grow to USD 26.41 billion by 2032

𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

Narcotics are also called opioids. Opioids are drugs prescribed to manage intense or long-lasting pain, like chronic headaches and backaches, for individuals recuperating from surgeries or dealing with severe pain related to cancer, as well as for adults and children who have sustained injuries while playing sports or due to falls, car accidents, or other events. Opioids are commonly prescribed medications for managing moderate to severe chronic pain. These pain relievers are administered to control pain in cancer patients and alleviate intense, ongoing pain in individuals with terminal illnesses.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.polarismarketresearch.com/industry-analysis/opioid-market/request-for-sample

𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:

The increasing occurrence of long-term illnesses like cancer and diabetes is fueling market expansion in the projected period. As chronic conditions continue to increase, the market for opioids is expected to keep growing. The elderly population is likely to choose pain relief methods, leading to a significant increase in pain suppression medications.

𝐊𝐞𝐲 𝐏𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬:

In this extremely competitive market, major rivals constantly innovate and differentiate their products in an effort to take the lead in the market. Some of the major players participating in the opioid market:

• AbbVie Inc.
• Actavis Plc.
• Amneal Pharmaceuticals LLC, Boehringer Ingelheim International GmbH
• Cadila Healthcare Limited
• Fresenius Kabi
• Mallinckrodt Pharmaceuticals
• Endo International plc
• Johnson & Johnson Corporation
• Lupin Limited
• Nesher Pharmaceuticals (USA) LLC
• Purdue Pharma L.P.
• Pfizer Inc.
• Rhodes Pharmaceuticals L.P.
• Sun Pharmaceutical Industries Limited
• Trevena Inc.
• Teva Pharmaceutical Industries Ltd

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐞𝐟𝐨𝐫𝐞 𝐩𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/opioid-market/inquire-before-buying

𝐂𝐨𝐮𝐧𝐭𝐫𝐲-𝐖𝐢𝐬𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

The opioid market is mainly segmented based on class, release type, product, application, and region. Based on the release type analysis, the extended-release segment is anticipated to witness the fastest growth. ER pain medications offer better and improved pain management during nighttime, reducing the condition for patients with chronic noncancer pain to wake up in the middle of the night for additional doses of medication and decreasing their time spent checking the clock.

Moreover, according to the application analysis, in 2021, the pain management segment held the highest market share. The market is expected to expand quickly due to the significant increase in individuals suffering from chronic headaches and back pain, patients recovering from surgery or tolerating severe pain from cancer, and individuals injured during sports, auto accidents, or other incidents.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/opioid-market

𝐎𝐩𝐢𝐨𝐢𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• The long-acting opioids segment is anticipated to grow at the highest CAGR over the forecast period. These drugs are frequently used to treat moderate to severe chronic pain. These medications offer therapeutic advantages such as consistent, long-lasting analgesia and reduced dose frequency.
• Semi-synthetic opioids segment accounted for to growth rapidly of the global revenue share due to the increased availability and demand for these painkillers. Labs use natural opiates to create semi-synthetic types.
• Asia-Pacific is expected to grow prominently over the projected period. This can be attributed to cancer cases rising across several developing economies. Nearly half of cancer's worldwide burden is borne by Asia. Additionally, a growing elderly population and an increase in cases of chronic pain would increase regional market demand.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐏𝐌𝐑'𝐬 𝐄𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐨𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐃𝐨𝐦𝐚𝐢𝐧:
Glaucoma Market: https://www.polarismarketresearch.com/industry-analysis/glaucoma-market

Obesity Treatment Market: https://www.polarismarketresearch.com/industry-analysis/obesity-treatment-market

Opioid Market: https://www.polarismarketresearch.com/industry-analysis/opioid-market

Ovarian Cancer Market: https://www.polarismarketresearch.com/industry-analysis/ovarian-cancer-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.